Both this study and our results suggest that the ability of PBMCs to express IL-2 in SLE patients is not significantly down regulated, there may be some other mechanisms that affect the detection level and function of IL-2 in SLE patients. The gene discussed is IL2; the disease is systemic lupus erythematosus.